Reagents
Closed Solicitation Posted
- Solicitation number
- N6264521Q0040
- Agency
- Naval Supply Systems Command Department of the Navy, Department of Defense
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Place of performance
- Japan
Notice details come from SAM.gov. Updated .
About this opportunity
This solicitation seeks proposals to supply various laboratory reagents and supplies to medical facilities of the United States Naval Hospital located in Japan and Diego Garcia. The Department of the Navy, Naval Supply Systems Command requires delivery of brand name products from manufacturers including Alere, Bayer Diagnostics, and Thermo Scientific starting October 2021 through September 2022. Interested parties must submit capability statements by the closing date of this notice to be considered for award. The contractor must be an authorized distributor or reseller that can provide OEM warranties and compliance.
There are no set-aside restrictions for this requirement. The NAICS code is 325413 for Medical and Diagnostic Laboratories. Required supplies and delivery dates are listed in Attachment I through September 2022 with place of performance in Japan and Diego Garcia. No budget or value is provided but the goal is to consolidate reagents as needed for these medical facilities through the period of performance.
Notice text
United States Naval Hospital (USNH) Okinawa and Yokosuka, Japan; Branch Medical Clinics located in Atsugi, Iwakuni, and Sasebo, Japan; and the Health Service Department in Diego Garcia has a supply requirement for various types of test reagents and laboratory supplies. The brand name reagents are required (manufacturers include the following: Alere, Bayer Diagnostics, Bio laboratories, American Master Tech Scientific, Beckman Coulter, Bio Test Medical, Azer Scientific, Becton Dickinson, BioMerieux Vitek, Cancer Diagnostics, Fisher Scientific, Immucor Gamma, Lav Pulse Med/Energy Beam Sci 2, Ortho Clinical Diagnostics, Polymed Co, Remel, Simmler, Terumo, Trinity Biotech, Whatman, Dynarex, Globe Scientific, Kimberly Clark, LifeSign, Pacific Hemostasis, Quantimetrix, Sakura Finetek, Smiths Medical, Thermo Scientific, Wampole Lab/Inverness, Wilkens Anderson Co, EN Sciences, HemoCue, Kimble Chase, Orasure Tech, Phlebotic, Quidel, Siemens Medical, Streck Laboratories, Triangle Biomedical, and Wescor) to be consolidated as required and be drop shipped directly by the contractor to the medical facilities in Japan and Diego Garcia. Delivery will be required starting 01 October 2021 and continue until 30 September 2022.
Contractor shall be an Original Equipment Manufacturer (OEM) authorized dealer, authorized distributor or authorized reseller for the required supplies, such that OEM requires and warranties and FDA compliances are provided and maintained by the OEMs.
There are not set-aside restrictions for this requirement. The intended procurement will be classified under North America Industry Classification System (NAICS) 325413. This notice of intent is not a request for competitive proposals. However, parties interested in responding to this notice will need to submit technical data sufficient to determine capability in providing the same product. All capability statements received by the closing date of this synopsis will be considered by the Government. A determination by the Government not to compete based on responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement.
Attachments
| File | Type | Posted |
|---|---|---|
| Attachment I-Reagents List.xlsx | XLSX spreadsheet | |
| RFQ N6264521Q0040.pdf |
Notice history
| Notice | Type | Posted |
|---|---|---|
| Reagents | Solicitation | |
| Reagents | Special Notice |
On GovTribe
Work this opportunity on GovTribe
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity